NCT06829901 The Effect of Uterine Entry In Fetoscopic Laser Photocoagulation for Twin-To-Twin Transfusion Syndrome
| NCT ID | NCT06829901 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor College of Medicine |
| Condition | Twin to Twin Transfusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 216 participants |
| Start Date | 2025-03-14 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 216 participants in total. It began in 2025-03-14 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate whether the entry technique surgeons use to get inside the uterus to perform fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome has an effect on the rates of chorioamniotic membrane separation.
Eligibility Criteria
Inclusion Criteria: * Patients who are eligible and elect to undergo fetoscopic selective laser photocoagulation for complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome. * Patients will be between 16 0/7 weeks and 26 0/7 weeks gestational age. Exclusion Criteria: * Patients who do not elect to undergo fetoscopic laser photocoagulation for the treatment of complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome. * Triplets and higher order multiple gestations. * Patients who are less than 16 0/7 weeks or greater than 26 0/7 weeks gestational age. * Patients with a short cervix (less than 1.5 cm). * Patients with a known subchorionic hemorrhage.
Contact & Investigator
Ahmed Nassr, MD, PhD
PRINCIPAL INVESTIGATOR
Baylor College of Medicine
Frequently Asked Questions
Who can join the NCT06829901 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Twin to Twin Transfusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06829901 currently recruiting?
Yes, NCT06829901 is actively recruiting participants. Contact the research team at ahmed.nassr@bcm.edu for enrollment information.
Where is the NCT06829901 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06829901 clinical trial?
NCT06829901 is sponsored by Baylor College of Medicine. The principal investigator is Ahmed Nassr, MD, PhD at Baylor College of Medicine. The trial plans to enroll 216 participants.